Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial

被引：11
|
作者：
Baolin, Tang
Lee, Jongbok
Cheng, Siqi
Yao, Wen
Wang, Dongyao
Tu, Meijuan
Xiang, Zhiqiang
Geng, Liangquan
Wang, Mingxia
Qiang, Ping
Teng, Pingping
Sun, Guangyu
Pan, Tianzhong
Liu, Huilan
Yang, Liming
Sun, Zimin
Zhang, Li
Zhu, Xiaoyu
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Ex vivo generation of donor-derived WT1-specific cytotoxic T-cells able to lyse patient's leukaemia blasts for adoptive immunotherapy after allogeneic haematopoietic stem cell transplantation
    Turin, I.
    Lisini, D.
    Montini, E.
    Caliogna, L.
    Moretta, A.
    Bonetti, F.
    Zavras, N.
    Grecchi, I.
    Zecca, M.
    Maccario, R.
    Montagna, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S320 - S320
  • [32] Adoptive Transfer of CMV- and EBV-Specific Peptide-Stimulated T Cells after Allogeneic Stem Cell Transplantation: First Results of a Phase I/IIa Clinical Trial [Multivir-01]
    Gary, Regina
    Aigner, Michael
    Moosmann, Andreas
    Ritter, Julia
    Seitz, Volkhard
    Moi, Stephanie
    Schaffer, Stefanie
    Balzer, Heidi
    Maas, Stefanie
    Strobel, Julian
    Zimmermann, Robert
    Zingsem, Juergen
    Kremer, Anita
    Hennig, Steffen
    Hummel, Michael
    Mackensen, Andreas
    Gerbitz, Armin
    BLOOD, 2016, 128 (22)
  • [33] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
    de la Portilla, F.
    Alba, F.
    Garcia-Olmo, D.
    Herrerias, J. M.
    Gonzalez, F. X.
    Galindo, A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (03) : 313 - 323
  • [34] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
    F. de la Portilla
    F. Alba
    D. García-Olmo
    J. M. Herrerías
    F. X. González
    A. Galindo
    International Journal of Colorectal Disease, 2013, 28 : 313 - 323
  • [35] Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study
    Shah, Nina
    Li, Li
    Kaur, Indreshpal
    McCarty, Jessica
    Yvon, Eric
    Shaim, Hila
    Muftuoglu, Muharrem
    Liu, Enli
    Sobieski, Catherine
    Orlowski, Robert Z.
    Cooper, Laurence J. N.
    Lee, Dean A.
    Parmar, Simrit
    Cao, Kai
    Hosing, Chitra M.
    Ahmed, Sairah
    Nieto, Yago
    Bashir, Qaiser
    Patel, Krina K.
    Bollard, Catherine M.
    McNiece, Ian K.
    Qazilbash, Muzaffar
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    BLOOD, 2015, 126 (23)
  • [36] A PHASE I/II CLINICAL TRIAL OF ALLOGENEIC EX VIVO EXPANDED CORNEAL EPITHELIAL STEM CELLS IN PATIENTS WITH SEVERE OCULAR SURFACE DISORDER ARISING FROM LIMBAL STEM CELL DEFICIENCY
    Turner, M.
    Bienek, C.
    McGowan, N.
    Dhillon, B.
    Campbell, J.
    Glover, A.
    CYTOTHERAPY, 2017, 19 (05) : S134 - S134
  • [37] Feasibility and safety of allogeneic ex vivo activated-NK cell infusion after matched related hematopoietic stem cell transplantation: Preliminary results of a prospective phase I trial
    Calmels, B.
    Devillier, R.
    Guia, S.
    Mfarrej, B.
    Furst, S.
    Harbi, S.
    Granata, A.
    Faucher, C.
    Izadifar, F.
    Makni, B.
    Vicari, O.
    Lignee, P.
    Lemarie, C.
    Fauriat, C.
    Olive, D.
    Vivier, E.
    Chabannon, C.
    Ugolini, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S155 - S155
  • [38] FEASIBILITY AND SAFETY OF ALLOGENEIC EX VIVO ACTIVATED-NK CELL INFUSION AFTER MATCHED RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE I TRIAL
    Calmels, B.
    Devillier, R.
    Guia, S.
    Mfarrej, B.
    Furst, S.
    Harbi, S.
    Granata, A.
    Faucher, C.
    Izadifar, F.
    Makni, B.
    Vicari, O.
    Lignee, P.
    Lemarie, C.
    Fauriat, C.
    Olive, D.
    Vivier, E.
    Chabannon, C.
    Ugolini, S.
    Blaise, D.
    CYTOTHERAPY, 2017, 19 (05) : S16 - S16
  • [39] Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
    Cruz, Conrad Russell Y.
    Micklethwaite, Kenneth P.
    Savoldo, Barbara
    Ramos, Carlos A.
    Lam, Sharon
    Ku, Stephanie
    Diouf, Oumar
    Liu, Enli
    Barrett, A. John
    Ito, Sawa
    Shpall, Elizabeth J.
    Krance, Robert A.
    Kamble, Rammurti T.
    Carrum, George
    Hosing, Chitra M.
    Gee, Adrian P.
    Mei, Zhuyong
    Grilley, Bambi J.
    Heslop, Helen E.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Bollard, Catherine M.
    Dotti, Gianpietro
    BLOOD, 2013, 122 (17) : 2965 - 2973
  • [40] One Year Follow up of Three Phase IB/IIA Clinical Trials of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulizing Crohn's Disease
    Lightner, A.
    Pineiro, A. Otero
    Reese, J.
    Ream, J.
    Nachand, D.
    Obi, M.
    Adams, A.
    VanDenBossche, A.
    Dadgar, N.
    Hull, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 555 - 555
12345